Literature DB >> 3133129

Interlaboratory comparison of antisera and immunoassays for benzo[a]pyrene-diol-epoxide-I-modified DNA.

R M Santella1, A Weston, F P Perera, G T Trivers, C C Harris, T L Young, D Nguyen, B M Lee, M C Poirier.   

Abstract

An interlaboratory comparison of immunoassays using antisera elicited against benzo[a]pyrene-diol-epoxide-modified DNA (BPDE-I-DNA) was carried out resulting in standardization of antisera, competitors and assay conditions. The assays used included competitive enzyme-linked immunosorbent assays (ELISA) with color and fluorescence endpoint detection and an ultrasensitive enzyme radioimmunoassay (USERIA) with a radioactive endpoint. Three different antisera were compared, two of which were obtained from different rabbits immunized with the same BPDE-I-DNA and a third from an animal immunized with another BPDE-I-DNA sample. Samples of standardized BPDE-I-DNA with high (36 pmol adduct/microgram DNA; 1.2 adducts/10(2) nucleotides) and low (4.5 fmol/microgram DNA; 1.5 adducts/10(6) nucleotides) modification levels were prepared and used in each laboratory. The antisera were all elicited against DNAs modified to a high extent, and it was therefore not surprising that they detected adducts in a slightly modified DNA sample with lower efficiency than those in highly modified DNA samples. The discrepancy of antibody recognition between the highly and slightly modified samples varied between 1.4- and 11.2-fold depending on the antiserum and assay. To ascertain the quantitative capability of the immunoassays, the modification level of DNA isolated from mouse keratinocytes treated with [3H]benzo[a]pyrene was determined by radioactivity and immunoassay. These results indicated that when a biological sample is assayed against a BPDE-I-DNA standard modified in the same range as the biological samples (4.5 fmol/microgram), quantitative recovery of adducts is achieved by immunoassay. These studies resulted in the realization that interlaboratory differences in immunoassay procedure can have significant consequences for data comparison and that where possible it is preferable for laboratories to use the same antisera and modified DNA standards.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3133129     DOI: 10.1093/carcin/9.7.1265

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  16 in total

1.  Human exposure to genotoxic carcinogens: methods and their limitations.

Authors:  H Autrup
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  Development and validation of a direct sandwich chemiluminescence immunoassay for measuring DNA adducts of benzo[a]pyrene and other polycyclic aromatic hydrocarbons.

Authors:  Panagiotis Georgiadis; Katalin Kovács; Stella Kaila; Paraskevi Makedonopoulou; Livia Anna; Miriam C Poirier; Lisbeth E Knudsen; Bernadette Schoket; Soterios A Kyrtopoulos
Journal:  Mutagenesis       Date:  2012-05-18       Impact factor: 3.000

3.  Detection of benzo[a]pyrene diol epoxide-DNA adducts in human placenta.

Authors:  D K Manchester; A Weston; J S Choi; G E Trivers; P V Fennessey; E Quintana; P B Farmer; D L Mann; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

4.  Modulations of benzo[a]pyrene-induced DNA adduct, cyclin D1 and PCNA in oral tissue by 1,4-phenylenebis(methylene)selenocyanate.

Authors:  Kun-Ming Chen; Peter G Sacks; Thomas E Spratt; Jyh-Ming Lin; Telih Boyiri; Joel Schwartz; John P Richie; Ana Calcagnotto; Arunangshu Das; James Bortner; Zonglin Zhao; Shantu Amin; Joseph Guttenplan; Karam El-Bayoumy
Journal:  Biochem Biophys Res Commun       Date:  2009-04-01       Impact factor: 3.575

5.  Production and characterization of monoclonal antibodies to N7-phenylguanine.

Authors:  C Schell; C Verkoyen; E Krewet; G Müller; K Norpoth
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

6.  CYP1A1 protein activity is associated with allelic variation in pterygium tissues and cells.

Authors:  Mei-Ling Peng; Yi-Yu Tsai; Chun-Chi Chiang; Ying-Che Huang; Ming-Chih Chou; Kun-Tu Yeh; Huei Lee; Ya-Wen Cheng
Journal:  Mol Vis       Date:  2012-07-18       Impact factor: 2.367

Review 7.  Human DNA adduct measurements: state of the art.

Authors:  M C Poirier; A Weston
Journal:  Environ Health Perspect       Date:  1996-10       Impact factor: 9.031

Review 8.  Measurement of chromosomal aberrations, sister chromatid exchange, hprt mutations, and DNA adducts in peripheral lymphocytes of human populations at increased risk for cancer.

Authors:  D Jacobson-Kram; R J Albertini; R F Branda; M T Falta; P T Iype; K Kolodner; S H Liou; M A McDiarmid; M Morris; J A Nicklas
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

9.  DNA adducts as biomarkers for assessing exposure to polycyclic aromatic hydrocarbons in tissues from Xuan Wei women with high exposure to coal combustion emissions and high lung cancer mortality.

Authors:  J L Mumford; X Lee; J Lewtas; T L Young; R M Santella
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

10.  Biomarkers of carcinogen exposure and cancer risk in a coke plant.

Authors:  G Assennato; G M Ferri; M S Tockman; M C Poirier; B Schoket; A Porro; V Corrado; P T Strickland
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.